Physician
Lamotte Pediatrics, LLP
Lamotte Pediatrics, LLP was paid $9.38M by Medicaid between Nov 2018 and Dec 2024, across 69 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoLAMOTTE PEDIATRICS, LLP
HENDERSON, NV 89052
HENDERSON, NV 89052
33aNPI1982797601assigned 10/02/2006
33bProvider typePediatrics Physician
28Total paid$9.38M
24GClaims271,049
24DCodes billed69
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#4 of 267
Median peer was paid$116K
This provider vs. median81×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 576 | $30K | |
| 2019 | 46,033 | $1.55M | |
| 2020 | 40,279 | $1.33M | |
| 2021 | 45,108 | $1.54M | |
| 2022 | 51,633 | $1.82M | |
| 2023 | 49,615 | $1.83M | |
| 2024incomplete | 37,805 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 54,122 | 48,721 | $3.08M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 18% | 20,133 | 18,835 | $1.70M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 14% | 28,875 | 27,693 | $1.30M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 11,353 | 10,917 | $980K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.4% | 8,723 | 8,000 | $692K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 6.5% | 15,488 | 14,998 | $611K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.1% | 2,358 | 2,260 | $200K |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.1% | 2,175 | 2,008 | $197K |
| 99460 | 1.8% | 2,085 | 1,954 | $170K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 666 | 641 | $63K |
| 90670 | <1% | 8,555 | 8,335 | $46K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,877 | 1,758 | $43K |
57 more codes
| 94760 | <1% | 22,883 | $41K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 997 | $34K |
| 54150 | <1% | 313 | $33K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,755 | $24K |
| 90698 | <1% | 3,626 | $19K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,380 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,284 | $16K |
| 99463 | <1% | 153 | $15K | |
| 85018 | <1% | 10,559 | $15K | |
| 81002 | <1% | 9,344 | $15K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 729 | $14K |
| 99383 | <1% | 71 | $7K | |
| A4250 | Urine test or reagent strips or tablets (100 tablets or strips) | <1% | 8,231 | $7K |
| A4550 | Surgical trays | <1% | 576 | $6K |
| 36416 | <1% | 2,341 | $6K | |
| 96127 | <1% | 1,230 | $5K | |
| 90680 | <1% | 5,948 | $4K | |
| 90633 | <1% | 2,767 | $2K | |
| 90744 | <1% | 1,499 | $2K | |
| 90686 | <1% | 1,551 | $2K | |
| 90671 | <1% | 2,963 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 74 | $1K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| 84030 | <1% | 503 | $1K | |
| 69210 | <1% | 28 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 70 | $982.73 |
| 94761 | <1% | 326 | $842.36 | |
| 99173 | <1% | 7,176 | $759.69 | |
| 0071A | <1% | 18 | $550.18 | |
| 90716 | <1% | 398 | $412.44 | |
| 99000 | <1% | 13,091 | $291.30 | |
| 64450 | <1% | 408 | $276.26 | |
| G8482 | Influenza immunization administered or previously received | <1% | 1,710 | $253.75 |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 408 | $245.05 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 116 | $177.98 |
| 90696 | <1% | 198 | $177.16 | |
| 90734 | <1% | 14 | $133.32 | |
| 90707 | <1% | 264 | $77.27 | |
| 90700 | <1% | 158 | $74.56 | |
| 90710 | <1% | 179 | $67.68 | |
| 90651 | <1% | 304 | $44.45 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | $10.79 |
| 90697 | <1% | 1,719 | $1.90 | |
| 91307 | <1% | 43 | $0.13 | |
| 90619 | <1% | 251 | $0.11 | |
| 90620 | <1% | 17 | $0.08 | |
| 99051 | 0% | 169 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 1,165 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 323 | $0.00 |
| 90715 | 0% | 97 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 14 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 40 | $0.00 |
| A6217 | Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing | 0% | 559 | $0.00 |
| 97802 | 0% | 1,265 | $0.00 | |
| 90647 | 0% | 129 | $0.00 | |
| 90656 | 0% | 130 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAMOTTE-MALONE, KIM (MANAGING PARTNER)